Aveley, United Kingdom

Jeffrey Clifford Jerman

This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignee: Smithkline Beecham Corporation. Active years: 1999-2001.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jeffrey Clifford Jerman. Retrieved from https://idiyas.com/inventor/jeffrey-clifford-jerman

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 2 

% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 1999-2001

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovations of Jeffrey Clifford Jerman

Introduction

Jeffrey Clifford Jerman is a notable inventor based in Aveley, GB. He has made significant contributions to the field of pharmaceuticals, particularly in the development of anti-convulsant compounds. With a total of 2 patents to his name, Jerman's work has the potential to impact the treatment of various neurological conditions.

Latest Patents

Jerman's latest patents include innovative technologies such as a receptor that binds anti-convulsant compounds and screening methods to identify these compounds. These inventions demonstrate his commitment to advancing medical science and improving patient outcomes.

Career Highlights

Jeffrey Jerman is currently employed at SmithKline Beecham Corporation, where he continues to work on groundbreaking research. His role at the company allows him to collaborate with other talented professionals in the field.

Collaborations

Throughout his career, Jerman has worked alongside esteemed colleagues such as Hugh Jonathan Herdon and Wai Ngor Chan. These collaborations have fostered an environment of innovation and creativity, leading to the development of impactful inventions.

Conclusion

In summary, Jeffrey Clifford Jerman is a dedicated inventor whose work in the pharmaceutical industry is paving the way for new treatments. His contributions are invaluable, and his ongoing research promises to yield further advancements in medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…